Amgen Reports Results of ABP 654 (biosimilar, ustekinumab) in P-III Study for the Treatment of Plaque Psoriasis
Shots: The company reported the preliminary results from a P-III study to evaluate...
Real-World Study Demonstrated Economic Benefits of Pegfilgrastim Biosimilar for the Prevention of Febrile Neutropenia
Shots: The real-world study evaluates the cost-effectiveness of pegfilgrastim bios...
Pfizer Reports Results of PF-06410293 (biosimilar, adalimumab) in the Sub-Study for the Treatment of Rheumatoid Arthritis
Shots: The sub-study of a P-III trial of PF-06410293 which was available for inj....
Amneal Receives the US FDA’s Approval for Alymsys (biosimilar, bevacizumab)
Shots: The US FDA has approved the BLA for bevacizumab-maly, a biosimilar referenc...
Biosimilar Solutions Reports the Initiation of Registrational Clinical Trials for Biosimilar BSC0826 to Treat Cancer
Shots: The company initiates its registrational clinical trial to evaluate the bio...
Celltrion Launches Yuflyma (biosimilar, adalimumab) for the Treatment of Multiple Chronic Inflammatory Disease in Canada
Shots: The company reported the commercial availability of Yuflyma in Canada as a...
